Journal of Shanghai Jiao Tong University (Medical Science) >
Association analysis of T cell receptor repertoire diversity with clinical characteristics and Fusobacterium nucleatum abundance in colorectal cancer patients
Received date: 2022-01-24
Accepted date: 2022-05-27
Online published: 2022-07-25
Supported by
Shanghai Municipal Education Commission—Gaofeng Clinical Medicine Grant Support(20161309)
Objective ·To analyze the association between T cell receptor repertoire diversity in colorectal cancer (CRC) patients and clinical characteristics and Fusobacterium nucleatum (Fn) abundance. Methods ·Sixty-three surgical CRC specimens and adjacent normal mucosa tissues were collected from the Department of Gastrointestinal Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine. Totally 53-paired qualified samples were subsequently sequenced on an Illumina HiSeq 4000 for paired-end 150 bp (PE150) sequencing. Quality control and genome annotation were carried out for the original sequencing data. Then a TRUST4 algorithm was further used to acquire TCR repertoire information from RNA sequencing results of tumor tissues and adjacent normal tissues. Meanwhile, the specific sequences of all samples' 16S rDNA were selected for high-throughput sequencing analysis. Clustered from the sequencing data after quality control, the operational taxonomic units (OTU) information was annotated based on rdp_16s_v16.fa taxonomic database to acquire bacterial abundance information, especially Fn. Immunarch R package was utilized to evaluate the characteristics of TCR repertoire clonotypes and diversity. Chao1 index, inverse Simpson index and Hill numerical curve were then conducted to assess the TCR repertoire diversity. Clinical features, such as gender, age, tumor location, and TNM stage, and biological factors like Fn load, were included to dichotomize patients into different groups, and repertoire diversity comparison between subgroups within different clinical features and Fn loads was conducted by Wilcoxon test subsequently. Results ·The number of TCR repertoire clonotypes in CRC tissues was lower compared to that in adjacent normal tissues (P=0.000). Chao1 index, inverse Simpson index and Hill number in tumor tissues were significantly lower than those in adjacent normal tissues (P=0.000). The Chao1 indexes, and inverse Simpson indexes between different gender, age (≥65 years vs <65 years) or TNM stage (Ⅰ/Ⅱ stage vs Ⅲ/Ⅳ stage) group showed no statistically significant difference (P>0.05). Tumors located in rectum had higher TCR clonotypes than those located in non-rectum (P=0.040). In addition, CRC patients with high Fn load demonstrated lower Chao1 indexes than those with low Fn load (P=0.030). Conclusion ·The TCR repertoire diversity is correlated with multiple clinical features as well as the abundance of Fn, indicating that the analysis based on TCR repertoire diversity of CRC patients can provide potential value for CRC tumorigenesis and development.
Muni HU , Linhua JI , Xinyu ZHANG , Chaoqin SHEN , Jie HONG , Haoyan CHEN . Association analysis of T cell receptor repertoire diversity with clinical characteristics and Fusobacterium nucleatum abundance in colorectal cancer patients[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022 , 42(8) : 1045 -1052 . DOI: 10.3969/j.issn.1674-8115.2022.08.009
1 | SIEGEL R L, MILLER K D, GODING SAUER A, et al. Colorectal cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(3): 145-164. |
2 | HARUKI K, KOSUMI K, HAMADA T, et al. Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer[J]. J Pathol, 2020, 250(4): 397-408. |
3 | YU T, GUO F F, YU Y N, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy[J]. Cell, 2017, 170(3): 548-563.e16. |
4 | MIMA K, NISHIHARA R, QIAN Z R, et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis[J]. Gut, 2016, 65(12): 1973-1980. |
5 | VUJOVIC M, DEGN K F, MARIN F I, et al. T cell receptor sequence clustering and antigen specificity[J]. Comput Struct Biotechnol J, 2020, 18: 2166-2173. |
6 | CHEN M, CHEN R Z, JIN Y, et al. Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer[J]. Nat Commun, 2021, 12(1): 6655. |
7 | SIMNICA D, AKYüZ N, SCHLIFFKE S, et al. T cell receptor next-generation sequencing reveals cancer-associated repertoire metrics and reconstitution after chemotherapy in patients with hematological and solid tumors[J]. Oncoimmunology, 2019, 8(11): e1644110. |
8 | SONG L, COHEN D, OUYANG Z Y, et al. TRUST4: immune repertoire reconstruction from bulk and single-cell RNA-seq data[J]. Nat Methods, 2021, 18(6): 627-630. |
9 | SHAO H W, LIN Y M, WANG T, et al. Identification of peptide-specific TCR genes by in vitro peptide stimulation and CDR3 length polymorphism analysis[J]. Cancer Lett, 2015, 363(1): 83-91. |
10 | LOONEY T J, TOPACIO-HALL D, LOWMAN G, et al. TCR convergence in individuals treated with immune checkpoint inhibition for cancer[J]. Front Immunol, 2020, 10: 2985. |
11 | STEWART J J, LEE C Y, IBRAHIM S, et al. A Shannon entropy analysis of immunoglobulin and T cell receptor[J]. Mol Immunol, 1997, 34(15): 1067-1082. |
12 | HOPKINS A C, YARCHOAN M, DURHAM J N, et al. T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma[J]. JCI Insight, 2018, 3(13): e122092. |
13 | HAN J F, DUAN J C, BAI H, et al. TCR repertoire diversity of peripheral PD-1+ CD8+ T cells predicts clinical outcomes after immunotherapy in patients with non-small cell lung cancer[J]. Cancer Immunol Res, 2020, 8(1): 146-154. |
14 | JOSHI K, MILIGHETTI M, CHAIN B M. Application of T cell receptor (TCR) repertoire analysis for the advancement of cancer immunotherapy[J]. Curr Opin Immunol, 2022, 74: 1-8. |
15 | AMIN M B, GREENE F L, EDGE S B, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging[J]. CA Cancer J Clin, 2017, 67(2): 93-99. |
16 | BUHLER S, BETTENS F, DANTIN C, et al. Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation[J]. Leukemia, 2020, 34(5): 1422-1432. |
17 | FARMANBAR A, KNELLER R, FIROUZI S. RNA sequencing identifies clonal structure of T-cell repertoires in patients with adult T-cell leukemia/lymphoma[J]. NPJ Genom Med, 2019, 4: 10. |
18 | CHARLES J, MOURET S, CHALLENDE I, et al. T-cell receptor diversity as a prognostic biomarker in melanoma patients[J]. Pigment Cell Melanoma Res, 2020, 33(4): 612-624. |
19 | SHERWOOD A M, EMERSON R O, SCHERER D, et al. Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue[J]. Cancer Immunol Immunother, 2013, 62(9): 1453-1461. |
/
〈 |
|
〉 |